Medicine and Dentistry
Patient
100%
Neoplasm
31%
Therapeutic Procedure
25%
Inpatient
23%
Non-Hodgkin Lymphoma
22%
Combination Therapy
21%
Diagnosis
21%
Malignant Neoplasm
20%
Cells
16%
Spontaneous Remission
16%
Breast Cancer
16%
Chemotherapy
15%
Hispanic
14%
Anemia
13%
Positron Emission Tomography
13%
Diseases
13%
Evaluation Study
12%
Lung
12%
Metastatic Carcinoma
12%
Gemcitabine
12%
Neck
12%
Patient Care
11%
Woman
11%
Hematology
11%
Receptor
10%
Toxicity
9%
Lymphoma
9%
Man
9%
Primary Tumor
9%
Age
8%
Percussion
8%
Corynebacterium minutissimum
8%
Clinical Trial
8%
Multiple Myeloma
8%
Pernicious Anemia
8%
Neutrophil
8%
Mycosis fungoides
8%
Laboratory
8%
Pneumonia
8%
Pleura Effusion
8%
Mean Platelet Volume
8%
Methemoglobinemia
8%
Alisertib
8%
Acquired Immune Deficiency Syndrome
8%
Delirium
8%
Cytarabine
8%
Pain
8%
Patient Referral
8%
Survival
7%
Chemotherapeutic Agent
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
27%
Drug
21%
Neoplasm
21%
Toxicity
20%
Protein P53
16%
Survival
14%
Malignant Neoplasm
10%
Diseases
10%
Progression Free Survival
10%
Delirium
8%
Cytarabine
8%
Receptor
8%
Chemotherapy Induced Nausea and Vomiting
8%
Insulin
8%
Calcium
8%
Pembrolizumab
8%
Pernicious Anemia
8%
Roflumilast
8%
Alisertib
8%
Nisoldipine
8%
Nonhodgkin Lymphoma
8%
Enterobacter
8%
Adverse Event
7%
Rituximab
7%
Cetuximab
7%
Liver Dysfunction
6%
Absence
6%
Overall Survival
6%
Anemia
6%
Pneumonia
6%
Phenylalanine
5%
Gemcitabine
5%
Bladder Cancer
5%
Classical Hodgkin Lymphoma
5%
Cobalamin
5%
Neurologic Disease
5%
Phosphotransferase
5%
Biological Marker
5%
